338 related articles for article (PubMed ID: 19281585)
1. Low-dose mifepristone in treatment of uterine leiomyoma: a randomised double-blind placebo-controlled clinical trial.
Bagaria M; Suneja A; Vaid NB; Guleria K; Mishra K
Aust N Z J Obstet Gynaecol; 2009 Feb; 49(1):77-83. PubMed ID: 19281585
[TBL] [Abstract][Full Text] [Related]
2. Open-label study of ultra low-dose mifepristone for the treatment of uterine leiomyomata.
Eisinger SH; Fiscella J; Bonfiglio T; Meldrum S; Fiscella K
Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):215-8. PubMed ID: 19586708
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of uterine leiomyoma by two different doses of mifepristone].
Yang Y; Zheng S; Li K
Zhonghua Fu Chan Ke Za Zhi; 1996 Oct; 31(10):624-6. PubMed ID: 9275461
[TBL] [Abstract][Full Text] [Related]
4. Twelve-month safety and efficacy of low-dose mifepristone for uterine myomas.
Eisinger SH; Bonfiglio T; Fiscella K; Meldrum S; Guzick DS
J Minim Invasive Gynecol; 2005; 12(3):227-33. PubMed ID: 15922980
[TBL] [Abstract][Full Text] [Related]
5. Mifepristone for treatment of uterine leiomyoma. A prospective randomized placebo controlled trial.
Engman M; Granberg S; Williams AR; Meng CX; Lalitkumar PG; Gemzell-Danielsson K
Hum Reprod; 2009 Aug; 24(8):1870-9. PubMed ID: 19389793
[TBL] [Abstract][Full Text] [Related]
6. Mifepristone for the treatment of uterine leiomyomas: a randomized controlled trial.
Carbonell Esteve JL; Acosta R; Heredia B; Pérez Y; Castañeda MC; Hernández AV
Obstet Gynecol; 2008 Nov; 112(5):1029-36. PubMed ID: 18978102
[TBL] [Abstract][Full Text] [Related]
7. Effect of mifepristone for symptomatic leiomyomata on quality of life and uterine size: a randomized controlled trial.
Fiscella K; Eisinger SH; Meldrum S; Feng C; Fisher SG; Guzick DS
Obstet Gynecol; 2006 Dec; 108(6):1381-7. PubMed ID: 17138770
[TBL] [Abstract][Full Text] [Related]
8. Treatment of uterine myoma with 5 or 10mg mifepristone daily during 6 months, post-treatment evolution over 12 months: double-blind randomised clinical trial.
Esteve JL; Acosta R; Pérez Y; Campos R; Hernández AV; Texidó CS
Eur J Obstet Gynecol Reprod Biol; 2012 Apr; 161(2):202-8. PubMed ID: 22269473
[TBL] [Abstract][Full Text] [Related]
9. Vaginal mifepristone for the treatment of symptomatic uterine leiomyomata: an open-label study.
Yerushalmi GM; Gilboa Y; Jakobson-Setton A; Tadir Y; Goldchmit C; Katz D; Seidman DS
Fertil Steril; 2014 Feb; 101(2):496-500. PubMed ID: 24220703
[TBL] [Abstract][Full Text] [Related]
10. A randomized, controlled trial of asoprisnil, a novel selective progesterone receptor modulator, in women with uterine leiomyomata.
Chwalisz K; Larsen L; Mattia-Goldberg C; Edmonds A; Elger W; Winkel CA
Fertil Steril; 2007 Jun; 87(6):1399-412. PubMed ID: 17307170
[TBL] [Abstract][Full Text] [Related]
11. Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial.
Muneyyirci-Delale O; Richard-Davis G; Morris T; Armstrong J
Clin Ther; 2007 Aug; 29(8):1682-91. PubMed ID: 17919549
[TBL] [Abstract][Full Text] [Related]
12. Systematic review of mifepristone for the treatment of uterine leiomyomata.
Steinauer J; Pritts EA; Jackson R; Jacoby AF
Obstet Gynecol; 2004 Jun; 103(6):1331-6. PubMed ID: 15172874
[TBL] [Abstract][Full Text] [Related]
13. Low dose mifepristone in medical management of uterine leiomyoma - an experience from a tertiary care hospital from north India.
Kulshrestha V; Kriplani A; Agarwal N; Sareen N; Garg P; Hari S; Thulkar J
Indian J Med Res; 2013 Jun; 137(6):1154-62. PubMed ID: 23852296
[TBL] [Abstract][Full Text] [Related]
14. Naproxen reduces idiopathic but not fibromyoma-induced menorrhagia.
Ylikorkala O; Pekonen F
Obstet Gynecol; 1986 Jul; 68(1):10-2. PubMed ID: 3523328
[TBL] [Abstract][Full Text] [Related]
15. Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas.
Magalhães J; Aldrighi JM; de Lima GR
Contraception; 2007 Mar; 75(3):193-8. PubMed ID: 17303488
[TBL] [Abstract][Full Text] [Related]
16. [A clinical control study on the treatment of uterine leiomyoma with gonadotrophin releasing hormone agonist or mifepristone].
Zeng C; Gu M; Huang H
Zhonghua Fu Chan Ke Za Zhi; 1998 Aug; 33(8):490-2. PubMed ID: 10806751
[TBL] [Abstract][Full Text] [Related]
17. Low-dose mifepristone for uterine leiomyomata.
Eisinger SH; Meldrum S; Fiscella K; le Roux HD; Guzick DS
Obstet Gynecol; 2003 Feb; 101(2):243-50. PubMed ID: 12576246
[TBL] [Abstract][Full Text] [Related]
18. [Effects of mifepristone on estrogen and progestin receptors in human uterine leiomyoma].
Wang H; Jin J
Zhonghua Fu Chan Ke Za Zhi; 2000 Feb; 35(2):79-81. PubMed ID: 11809103
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials.
Stewart EA; Diamond MP; Williams ARW; Carr BR; Myers ER; Feldman RA; Elger W; Mattia-Goldberg C; Schwefel BM; Chwalisz K
Hum Reprod; 2019 Apr; 34(4):623-634. PubMed ID: 30865281
[TBL] [Abstract][Full Text] [Related]
20. The effect of anastrazole on symptomatic uterine leiomyomata.
Varelas FK; Papanicolaou AN; Vavatsi-Christaki N; Makedos GA; Vlassis GD
Obstet Gynecol; 2007 Sep; 110(3):643-9. PubMed ID: 17766612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
